DNM1L and neoplasm: It has been shown that mitochondrial fission enhancement mediated by upregulation of DRP1 and mitochondrial fusion attenuation mediated by downregulation of MFN2 are associated with multiple cancers and promote tumor cell metastasis and drug tolerance, thus tumor progression (Ma et al., 2020; Ding et al., 2022a).